abstract |
Novel heterocyclic compounds of the formula I n n n n n n n n n n whereinn nD isn n n n n n n n n n n wherein R 1 , R 2 , E′, E″, E′″, Y″, Y″, G′, G″, G′″ and G′″ have the meaning of claim 1 ,n nare activators of glucokinase and can be used for the prevention and/or treatment of Diabetes Typ 1 and 2, obesity, neuropathy and/or nephropathy. |